Table 2 Changes in lipid levels in patients with type 2 diabetes mellitus after 10 weeks of treatment with atorvastatin or placebo.
| Group 1 (n = 15) | Group 2 (n = 15) | Group 3 (n = 15) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPDR (n = 8) | PDR (n = 7) | |||||||||||
| Baseline | After 10 weeks | p Value* | Baseline | After 10 weeks | p Value* | Baseline | After 10 weeks | p Value* | Baseline | After 10 weeks | p Value* | |
| TC | 180.2 (10.1) | 153.2 (7.3) | <0.001 | 191.6 (14.3) | 150.6 (10.1) | <0.001 | 178.1 (14.2) | 173.8 (11.7) | 0.340 | 178.2 (11.6) | 174.2 (14.0) | 0.546 |
| LDL‐C | 133.4 (8.6) | 98.9 (8.6) | <0.001 | 133.0 (10.9) | 102.1 (9.3) | <0.001 | 127.5 (9.9) | 124.2 (10.1) | 0.443 | 126.2 (7.0) | 125.4 (6.7) | 0.824 |
| HDL‐C | 41.9 (8.7) | 40.7 (8.40 | 0.645 | 40.0 (8.6) | 39.8 (8.3) | 0.720 | 40.8 (8.6) | 38.8 (9.7) | 0.237 | 37.2 (4.7) | 39.0 (8.8) | 0.345 |
| TG | 140.6 (7.3) | 111.9 (11.4) | <0.001 | 148.0 (12.1) | 115.4 (12.0) | <0.001 | 151.2 (14.8) | 146.7 (14.1) | 0.211 | 153.1 (15.7) | 147.8 (13.5) | 0.119 |
HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; NPDR, non‐proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; TC, total cholesterol; TG, triglycerides.
Values are mean (SD).
*p Value for comparison before and after atorvastatin and placebo treatment.